taspoglutide
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background and ObjectiveTaspoglutide, a glucagon-like peptide-1 agonist, like native glucagon-like peptide-1, delays gastric…
To evaluate single‐dose pharmacokinetics and tolerability of taspoglutide in people with varying degrees of renal impairment and…
To study the short‐term cardiovascular effects of the once‐weekly glucagon‐like peptide‐1 receptor agonist taspoglutide.
OBJECTIVE To evaluate the efficacy and safety of taspoglutide monotherapy in drug-naive patients with type 2 diabetes…
RESULTSdMean baseline HbA1c was 8.1%. Both doses of taspoglutide reduced HbA1c significantly more than exenatide (taspoglutide 10…
Aim: Glucagon‐like peptide‐1 (GLP‐1) has protective effects on pancreatic β‐cells. We evaluated the effects of a novel, long…
OBJECTIVE To evaluate the efficacy and safety of taspoglutide (R1583/BIM51077), a human once-weekly glucagon-like peptide-1…
Background: Taspoglutide (R1583/BIM51077) is a new anti diabetic drug from Hoffmann-La Roche. The compound is to be administered…
A highly sensitive liquid chromatographic method with online solid-phase extraction (SPE) and tandem mass spectrometric detection…